| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President | Chief Executive Officer
1 company
Novak Rodger is a President at CRISPR Therapeutics AG. Recent SEC Form 4 filings include 0 buys and 19 sells.
Estimated insider holdings value: $31.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 30, 2017 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 75,795 | $20.25 | $1,534,869.13 | -3.1% | |
| Jun 22, 2017 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 10,825 | $15.37 | $166,387.83 | -0.9% | |
| Jun 21, 2017 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 30,222 | $15.01 | $453,510.86 | -0.8% | |
| Jun 9, 2017 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 5,303 | $15.02 | $79,628.05 | -0.2% | |
| May 30, 2017 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 3,650 | $15.02 | $54,828.84 | -0.3% | |
| May 17, 2017 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 50,000 | $16.26 | $812,859.34 | -2.0% | |
| May 5, 2017 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 616 | $16.92 | $10,425.68 | - | |
| May 4, 2017 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 49,384 | $16.30 | $805,183.12 | -1.0% | |
| Apr 20, 2017 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 50,000 | $17.88 | $893,917.96 | -1.3% |